Rigel Pharmaceuticals (RIGL) PT Raised to $7 at Cantor Fitzgerald, Following Strategic Business Update

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/18/2021

1. WIT
2. WPRO:IN
3. AA
4. SPY
5. JBHT

6. UNH
7. C
8. SPLK
9. PHX
10. BLK

Top News Most Read Special Reports

Wall Street ends week positively; S&P 500, Dow hit record highs
Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
Dollar at 4-week low on retreating Treasury yields
J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report

February 18, 2021 2:54 PM EST

E-mail

Get Alerts RIGL Hot Sheet

Price: $3.58 -5.29%

Rating Summary:
7 Buy, 5 Hold, 0 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41

Trade Now!

Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Cantor Fitzgerald analyst Kristen Kluska raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $7.00 (from $5.00) while maintaining a Overweight rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Analyst PT Change

Related Entities

Cantor Fitzgerald

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!